PRESS RELEASE published on 09/06/2023 at 22:30, 2 years 11 months ago Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
PRESS RELEASE published on 09/06/2023 at 13:00, 2 years 11 months ago Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
PRESS RELEASE published on 08/30/2023 at 13:00, 2 years 11 months ago Moderna to Host Investor Event - R&D Day and Business Updates
PRESS RELEASE published on 08/17/2023 at 22:15, 2 years 11 months ago Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
PRESS RELEASE published on 08/03/2023 at 12:30, 3 years ago Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 07/13/2023 at 13:00, 3 years ago Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
PRESS RELEASE published on 07/05/2023 at 13:00, 3 years 1 month ago Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
PRESS RELEASE published on 07/03/2023 at 07:00, 3 years 1 month ago Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/22/2023 at 22:05, 3 years 1 month ago Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/05/2023 at 14:00, 3 years 2 months ago Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma
Published on 08/13/2026 at 12:00, 10 minutes ago Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Published on 08/13/2026 at 09:05, 3 hours 5 minutes ago Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
Published on 08/13/2026 at 08:00, 4 hours 10 minutes ago Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 4 hours 40 minutes ago Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/13/2026 at 00:30, 11 hours 40 minutes ago Aton Closes CAD$4 Million Private Placement
Published on 08/13/2026 at 11:54, 15 minutes ago 25 Years Redcare Pharmacy: From a digital pioneer to Europe’s leading online pharmacy.
Published on 08/13/2026 at 11:49, 20 minutes ago Form 8 - Genel Energy PLC: PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Published on 08/13/2026 at 11:10, 1 hour ago Omio expands global ground transport network with Greyhound Australia partnership
Published on 08/13/2026 at 11:05, 1 hour 5 minutes ago BIRKENSTOCK REPORTS FISCAL THIRD QUARTER 2026 RESULTS WITH 15% CONSTANT F/X REVENUE GROWTH LED BY DTC; RAISES GUIDANCE FOR FY26
Published on 08/11/2026 at 17:45, 1 day 18 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 18 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 18 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 18 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
